277 related articles for article (PubMed ID: 17137902)
21. Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept.
van Dijken TD; Vastert SJ; Gerloni VM; Pontikaki I; Linnemann K; Girschick H; Armbrust W; Minden K; Prince FH; Kokke FT; Nieuwenhuis EE; Horneff G; Wulffraat NM
J Rheumatol; 2011 Jul; 38(7):1441-6. PubMed ID: 21459936
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.
Foeldvari I; Wierk A
J Rheumatol; 2005 Feb; 32(2):362-5. PubMed ID: 15693100
[TBL] [Abstract][Full Text] [Related]
23. Early predictors of severe course of uveitis in oligoarticular juvenile idiopathic arthritis.
Zulian F; Martini G; Falcini F; Gerloni V; Zannin ME; Pinello L; Fantini F; Facchin P
J Rheumatol; 2002 Nov; 29(11):2446-53. PubMed ID: 12415607
[TBL] [Abstract][Full Text] [Related]
24. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study.
Saurenmann RK; Levin AV; Feldman BM; Rose JB; Laxer RM; Schneider R; Silverman ED
Arthritis Rheum; 2007 Feb; 56(2):647-57. PubMed ID: 17265500
[TBL] [Abstract][Full Text] [Related]
25. [Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database].
Heiligenhaus A; Niewerth M; Mingels A; Ganser G; Thon A; Pleyer U; Greiner K; Minden K
Klin Monbl Augenheilkd; 2005 Dec; 222(12):993-1001. PubMed ID: 16418970
[TBL] [Abstract][Full Text] [Related]
26. The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment.
Kanakoudi-Tsakalidou F; Tzimouli V; Pratsidou-Gertsi P; Chronopoulou E; Trachana M
Cytokine; 2008 Jun; 42(3):293-7. PubMed ID: 18445529
[TBL] [Abstract][Full Text] [Related]
27. IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors.
Cimaz R; Cazalis MA; Reynaud C; Gerloni V; Zulian F; Biggioggero M; Martini G; Pontikaki I; Fantini F; Mougin B; Miossec P
Ann Rheum Dis; 2007 Jul; 66(7):900-4. PubMed ID: 17324969
[TBL] [Abstract][Full Text] [Related]
28. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
Galor A; Perez VL; Hammel JP; Lowder CY
Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
[TBL] [Abstract][Full Text] [Related]
29. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?
Butbul YA; Tyrrell PN; Schneider R; Dhillon S; Feldman BM; Laxer RM; Saurenmann RK; Spiegel L; Cameron B; Tse SM; Silverman ED
J Rheumatol; 2009 Sep; 36(9):2033-41. PubMed ID: 19648305
[TBL] [Abstract][Full Text] [Related]
30. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
Zulian F; Balzarin M; Falcini F; Martini G; Alessio M; Cimaz R; Cimino L; Zannin ME
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
[TBL] [Abstract][Full Text] [Related]
31. TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? - an evidence based approach.
Winterhalter S; Niehues T
Klin Padiatr; 2008; 220(6):342-7. PubMed ID: 18949668
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis.
Sijssens KM; Rothova A; Van De Vijver DA; Stilma JS; De Boer JH
Am J Ophthalmol; 2007 Oct; 144(4):574-9. PubMed ID: 17706583
[TBL] [Abstract][Full Text] [Related]
33. Adalimumab in the therapy of uveitis in childhood.
Biester S; Deuter C; Michels H; Haefner R; Kuemmerle-Deschner J; Doycheva D; Zierhut M
Br J Ophthalmol; 2007 Mar; 91(3):319-24. PubMed ID: 17035274
[TBL] [Abstract][Full Text] [Related]
34. New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases.
Wendling D; Paccou J; Berthelot JM; Flipo RM; Guillaume-Czitrom S; Prati C; Dernis E; Direz G; Ferrazzi V; Ristori JM;
Semin Arthritis Rheum; 2011 Dec; 41(3):503-10. PubMed ID: 21862108
[TBL] [Abstract][Full Text] [Related]
35. Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and its implication for current screening guideline.
Sim KT; Venning HE; Barrett S; Gregson RM; Amoaku WM
Ocul Immunol Inflamm; 2006 Dec; 14(6):353-7. PubMed ID: 17162606
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
[TBL] [Abstract][Full Text] [Related]
37. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
Kimura Y; Pinho P; Walco G; Higgins G; Hummell D; Szer I; Henrickson M; Watcher S; Reiff A
J Rheumatol; 2005 May; 32(5):935-42. PubMed ID: 15868633
[TBL] [Abstract][Full Text] [Related]
38. Visual outcome in children with juvenile idiopathic arthritis related uveitis.
Raymaekers A; Foets B; Wouters C; Casteels I
Bull Soc Belge Ophtalmol; 2006; (300):67-72. PubMed ID: 16903513
[TBL] [Abstract][Full Text] [Related]
39. Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis.
Kasapçopur O; Yologlu N; Ozyazgan Y; Ercan G; Caliskan S; Sever L; Ozdogan H; Arisoy N
Indian Pediatr; 2004 Oct; 41(10):1035-9. PubMed ID: 15523130
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines.
Heiligenhaus A; Niewerth M; Ganser G; Heinz C; Minden K;
Rheumatology (Oxford); 2007 Jun; 46(6):1015-9. PubMed ID: 17403710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
